{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:27Z","timestamp":1791928947492,"version":"4.3.4"},"reference-count":38,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,2,9]]},"DOI":"10.1167\/iovs.67.2.23","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:30:49Z","timestamp":1770643849000},"page":"23","source":"Crossref","is-referenced-by-count":0,"title":["Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone"],"prefix":"10.1167","volume":"67","author":[{"given":"Allison K.","family":"Krebs","sequence":"first","affiliation":[{"name":"Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Diaz","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania, United States"},{"name":"Department of Biomedical Education and Data Science, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Sassani","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S.","family":"Zagon","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib3","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3390\/medicina61111992","article-title":"Beyond the surface: revealing the concealed effects of hyperglycemia on ocular surface homeostasis and dry eye disease","volume":"61","author":"Zeppieri","year":"2025","journal-title":"Medicina"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1001\/archophthalmol.2009.270","article-title":"Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus","volume":"127","author":"Zagon","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1177\/1535370220940273","article-title":"Dysregulation of the OGF-OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat","volume":"245","author":"Zagon","year":"2020","journal-title":"Exp Biol Med"},{"issue":"5","key":"bib6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/1535370220972060","article-title":"Blockade of the opioid growth factor receptor (OGFr) delays the onset and reduces the severity of diabetic ocular surface complications","volume":"246","author":"Zagon","year":"2021","journal-title":"Exp Biol Med"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"10175","DOI":"10.3389\/ebm.2024.10175","article-title":"Topical naltrexone increases aquaporin 5 production in the lacrimal gland and restores tear production in diabetic rats","volume":"249","author":"Diaz","year":"2024","journal-title":"Exp Biol Med"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33696\/diabetes.4.054","article-title":"Elevated opioid growth factor alters the limbus in type 1 diabetic rats","volume":"5","author":"McLaughlin","year":"2023","journal-title":"J. Diabetes Clin Res"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","article-title":"Cellular death, reactive oxygen species (ROS) and diabetic complications","volume":"9","author":"Volpe","year":"2018","journal-title":"Cell Death Disease"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"10866","DOI":"10.3390\/ijms241310866","article-title":"NLRP3 Inflammasome as a potential therapeutic target in dry eye disease","volume":"24","author":"Zhuang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.65.14.34","article-title":"Endoplasmic reticulum stress induces ROS production and activates NLRP3 inflammasome via the PERK-CHOP signaling pathway in dry eye disease","volume":"65","author":"Zha","year":"2024","journal-title":"Invest Ophthal Vis Sci"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.18240\/ijo.2022.05.20","article-title":"Inflammation and dry eye disease-where are we?","volume":"15","author":"Rao","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.7150\/ijbs.63219","article-title":"The advanced glycation end-products (AGEs)\/ROS\/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration","volume":"18","author":"Wan","year":"2022","journal-title":"Int J Biol Sci"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-024-06306-1","article-title":"Targeting the NLRP3 inflammasome-IL-1\u00df pathway in type 2 diabetes and obesity","volume":"68","author":"Meier","year":"2025","journal-title":"Diabetologia"},{"issue":"5","key":"bib15","doi-asserted-by":"publisher","first-page":"e0126277","DOI":"10.1371\/journal.pone.0126277","article-title":"Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients","volume":"19","author":"Niu","journal-title":"PloS One"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1111\/aos.13526","article-title":"Dry eye disease and oxidative stress","volume":"96","author":"Seen","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"bib17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/1535370220972060","article-title":"Blockade of the opioid growth factor receptor (OGFr) delays the onset and reduces the severity of diabetic ocular surface complications","volume":"246","author":"Zagon","year":"2021","journal-title":"Exp Biol Med"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3892\/etm.2021.10119","article-title":"Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats","volume":"22","author":"Purushothaman","year":"2021","journal-title":"Exp Ther Med"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"113436","DOI":"10.1016\/j.physbeh.2021.113436","article-title":"Sex differences in the magnitude of diabetic ocular surface complications: role of serum OGF","volume":"237","author":"Purushothaman","year":"2021","journal-title":"Physiol Behav"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bcp.2015.06.016","article-title":"Duration of opioid receptor blockade determines biotherapeutic response","volume":"97","author":"McLaughlin","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.66.3.24","article-title":"Reversal of diabetic dry eye by topical opioid receptor blockade follows dual pathways","volume":"66","author":"Diaz","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fimmu.2017.00809","article-title":"Naltrexone Inhibits IL-6 and TNFa production in human immune cell subsets following stimulation with ligands for intracellular toll-like receptors","volume":"8","author":"Cant","year":"2017","journal-title":"Front Immunol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"6572499","DOI":"10.1155\/2022\/6572499","article-title":"Effects of naltrexone on expression of lipid metabolism-related proteins in liver steatosis induced by endoplasmic reticulum stress in mice","volume":"2022","author":"Yang","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"bib24","first-page":"17448","article-title":"Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions","volume":"14","author":"Bennici","year":"2024","journal-title":"Royal Soc Chem"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0006-8993(98)00427-2","article-title":"Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors","volume":"798","author":"Zagon","year":"1998","journal-title":"Brain Res"},{"key":"bib26","first-page":"73","article-title":"Reepithelialization of the human cornea is regulated by endogenous opioid","volume":"41","author":"Zagon","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/jop.2006.22.377","article-title":"Corneal safety of topically applied naltrexone","volume":"22","author":"Zagon","year":"2006","journal-title":"J Ocul Pharmacol Therap"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/jop.2006.0111","article-title":"Topically applied naltrexone restores corneal reepithelialization in diabetic rats","volume":"23","author":"Klocek","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/jop.2015.0070","article-title":"Topical application of naltrexone to the corneal surface of healthy volunteers: a safety and tolerability study","volume":"32","author":"Liang","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib30","first-page":"66238","article-title":"High throughput screening assessment of reactive oxygen species (ROS) generation using dihydroethidium (DHE) fluorescence dye","volume":"203","author":"Kumar","year":"2024","journal-title":"J Vis Exp"},{"key":"bib31","first-page":"e66570","article-title":"Biomarkers of oxidative stress and their clinical relevance in type 2 diabetes mellitus patients: a systematic review","volume":"16","author":"Sabitha","year":"2024","journal-title":"Cureus"},{"key":"bib32","first-page":"2283","article-title":"Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease","volume":"42","author":"Solomon","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.2337\/diabetes.54.suppl_2.S114","article-title":"Interleukin-6 and diabetes. The good, the bad, or the indifferent?","volume":"54","author":"Kristiansen","year":"2005","journal-title":"Diabetes"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"110006","DOI":"10.1016\/j.exer.2024.110006","article-title":"IL-6 induces Treg dysfunction in desiccating stress-induced dry eye disease","volume":"246","author":"Ortiz","year":"2024","journal-title":"Exp Eye Res"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-a) in autoimmune disease and current TNF-a inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"16359","DOI":"10.1074\/jbc.RA120.013484","article-title":"Low-dose naltrexone rescues inflammation and insulin resistance associated with hyperinsulinemia","volume":"295","author":"Choubey","year":"2020","journal-title":"J Biol Chem"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"13507","DOI":"10.1038\/s41598-024-63942-8","article-title":"Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures","volume":"14","author":"Rodriguez","year":"2024","journal-title":"Sci Rep"},{"key":"bib38","doi-asserted-by":"crossref","DOI":"10.1177\/10807683251405622","article-title":"Topical Rho-associated protein kinase inhibit HA1077 reduces rabbit corneal fibrosis and neovasculariation in vivo","author":"Fink","year":"2025","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib1","article-title":"Eye health: dry eye with diabetes","author":"American Diabetes Association","year":"2023"},{"key":"bib2","article-title":"Diabetes. 2023 Jun 21","volume-title":"StatPearls","author":"Sapra","year":"2025"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.2.23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:16Z","timestamp":1791927136000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.2.23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.2.23","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,9]]}}}